These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31884591)

  • 1. RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies.
    Garanto A
    Adv Exp Med Biol; 2019; 1185():71-77. PubMed ID: 31884591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections.
    Malvasi M; Casillo L; Avogaro F; Abbouda A; Vingolo EM
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy for Inherited Retinal Disorders: Update on Clinical Trials.
    Michalakis S; Gerhardt M; Rudolph G; Priglinger S; Priglinger C
    Klin Monbl Augenheilkd; 2021 Mar; 238(3):272-281. PubMed ID: 33784790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for RPE65-related retinal disease.
    Miraldi Utz V; Coussa RG; Antaki F; Traboulsi EI
    Ophthalmic Genet; 2018 Dec; 39(6):671-677. PubMed ID: 30335549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.
    Garanto A; Collin RWJ
    Methods Mol Biol; 2018; 1715():61-78. PubMed ID: 29188506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.
    Gerard X; Garanto A; Rozet JM; Collin RW
    Adv Exp Med Biol; 2016; 854():517-24. PubMed ID: 26427454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first gene therapy for
    Ferraz Sallum JM; Godoy J; Kondo A; Kutner JM; Vasconcelos H; Maia A
    Ophthalmic Genet; 2022 Aug; 43(4):550-554. PubMed ID: 35416119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice.
    Murro V; Banfi S; Testa F; Iarossi G; Falsini B; Sodi A; Signorini S; Iolascon A; Russo R; Mucciolo DP; Caputo R; Bacci GM; Bargiacchi S; Turco S; Fortini S; Simonelli F
    Orphanet J Rare Dis; 2023 Jul; 18(1):223. PubMed ID: 37525225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia].
    Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI
    Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.
    Kang C; Scott LJ
    Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review.
    Sallum JMF; Kaur VP; Shaikh J; Banhazi J; Spera C; Aouadj C; Viriato D; Fischer MD
    Adv Ther; 2022 Mar; 39(3):1179-1198. PubMed ID: 35098484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy in Retinal Dystrophies.
    Ziccardi L; Cordeddu V; Gaddini L; Matteucci A; Parravano M; Malchiodi-Albedi F; Varano M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new landscape of retinal gene therapy.
    Ku CA; Pennesi ME
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voretigene neparvovec-rzyl (Luxturna) for inherited retinal dystrophy.
    Med Lett Drugs Ther; 2018 Mar; 60(1543):53-55. PubMed ID: 29635265
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene supplementation therapy for recessive forms of inherited retinal dystrophies.
    Smith AJ; Bainbridge JW; Ali RR
    Gene Ther; 2012 Feb; 19(2):154-61. PubMed ID: 22033465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dog models for blinding inherited retinal dystrophies.
    Petersen-Jones SM; Komáromy AM
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee.
    Han J; Joo K; Kim US; Woo SJ; Lee EK; Lee JY; Park TK; Kim SJ; Byeon SH
    Korean J Ophthalmol; 2023 Apr; 37(2):166-186. PubMed ID: 36950921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.